株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

甲状腺濾胞癌:世界の治験動向

Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 328413
出版日 ページ情報 英文 101 Pages
即納可能
価格
本日の銀行送金レート: 1USD=116.15円で換算しております。
Back to Top
甲状腺濾胞癌:世界の治験動向 Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016
出版日: 2016年10月30日 ページ情報: 英文 101 Pages
概要

当レポートでは、世界の甲状腺濾胞癌治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断 (一時中止、廃止、打ち切り) された試験のリストなどを提供しています。

イントロダクション

  • 甲状腺濾胞癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:癌治療薬の治験における甲状腺濾胞癌の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:癌治療薬の治験における甲状腺濾胞癌の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

甲状腺濾胞癌治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Bayer AG
    • エーザイ
    • Exelixis, Inc.
    • AstraZeneca PLC
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • University of Washington
    • University of Kentucky
    • University of California, San Francisco
    • MedStar Washington Hospital Center
    • Mashhad University of Medical Sciences
    • Memorial Sloan Kettering Cancer Center
    • University of Colorado
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • University of Michigan

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3865CTIDB

GlobalData's clinical trial report, "Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Follicular Thyroid Cancer Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 98

  • Abbreviations 98
  • Definitions 98
  • Research Methodology 99
  • Secondary Research 99
  • About GlobalData 100
  • Contact Us 100
  • Disclaimer 100
  • Source 101

List of Tables

List of Tables

  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
  • Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 15
  • Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 18
  • Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 21
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14
  • Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 15
  • Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
  • Follicular Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
  • Proportion of Follicular Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 18
  • Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Follicular Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
  • Follicular Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
  • Follicular Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Follicular Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 99
Back to Top